Fulvestrant does not stimulate endometrial growth in postmenopausal breast cancer patients

被引：0
|
作者：
Morales, L. [1 ]
Neven, P. [1 ]
Timmerman, D. [1 ]
Wildiers, H. [1 ]
Konstantinovic, M. L. [1 ]
Tan, P. N. [1 ]
Christiaens, M-R [1 ]
Paridaens, R. [1 ]
机构：
[1] Univ Hosp KU Leuven, Fac Med, Louvain, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [41] ONDANSETRON DOES NOT STIMULATE PROLACTIN-RELEASE IN BREAST-CANCER PATIENTS
    LISSONI, P
    CAZZANIGA, M
    ROVELLI, F
    MAININI, E
    TANCINI, G
    BARNI, S
    TUMORI, 1994, 80 (03) : 209 - 211
  • [42] Fulvestrant in pretreated postmenopausal patients with metastatic breast cancer: analysis from the French multicentre compassionate use programme
    Gligorov, J.
    Antoine, E. C.
    Dalenc, F.
    Namer, M.
    Chollet, P.
    Spielmann, M.
    Campone, M.
    Zelek, L.
    Debled, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S116 - S116
  • [43] Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
    Kumler, Iben
    Knoop, Ann S.
    Jessing, Christina A. R.
    Ejlertsen, Bent
    Nielsen, Dorte L.
    ESMO OPEN, 2016, 1 (04)
  • [44] Fulvestrant in heavily pretreated ER-positive postmenopausal metastatic breast cancer patients: A phase II study
    Ratti, R.
    Coccorullo, Z.
    Guarneri, D.
    Addamo, G.
    Colloca, G.
    Venturino, A.
    Campora, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Efficacy of fulvestrant in treating postmenopausal patients with estrogen receptor-positive metastatic breast cancer and prognostic analysis
    Li, Tao
    Jiao, Lianghe
    JOURNAL OF BUON, 2021, 26 (01): : 189 - 195
  • [46] Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogens
    Cohen, I
    Figer, A
    Altaras, MM
    Tepper, R
    Shapira, J
    Cordoba, M
    Yigael, D
    Arbel, Y
    Beyth, Y
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1996, 15 (01) : 17 - 22
  • [47] Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen
    Cecchini, S
    Ciatto, S
    Bonardi, R
    Mazzotta, A
    Grazzini, G
    Pacini, P
    Muraca, MG
    GYNECOLOGIC ONCOLOGY, 1996, 60 (03) : 409 - 411
  • [48] Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology
    Morales, Leilani
    Paridaens, Robert
    Timmerman, Dirk
    Neven, Patrick
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5603 - 5603
  • [49] Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: Is screening necessary?
    Lubian Lopez, Daniel Ma.
    Orihuela Lopez, Francisco
    Garcia-Berbel Molina, Lucia
    Boza Novo, Patricia
    Pozuelo Solis, Estrella
    Menor Almagro, David
    Comino Delgado, Rafael
    GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 56 - 62
  • [50] Different coexisting gynecological and endometrial pathologies in postmenopausal breast cancer patients treated with tamoxifen
    Cohen, I
    Beyth, Y
    Bernheim, J
    Shapira, J
    Cordoba, M
    Aviram, R
    Figer, A
    Yigael, D
    Altaras, MM
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 46 (02) : 123 - 129
12345